Newborn Screening Market: Dry Blood Spot Test to be Highly Lucrative Test Type

According to the report, the global newborn screening market was valued at ~US$ 940 Mn in 2019 and is projected to expand at a CAGR of ~11% from 2021 to 2031.

Newborn Screening Market: Introduction

According to the report, the global newborn screening market was valued at ~US$ 940 Mn in 2019 and is projected to expand at a CAGR of ~11% from 2021 to 2031. Newborn screening is a preventive pediatric screening test conducted to diagnose congenital or inborn abnormalities of metabolism in order to identify the disease. Newborn screening helps in the early detection of serious genetic diseases, which may result in disability or death if not treated at the initial stage. Different types of instrument and assay kits are used in the diagnosis of newborn disorders. Hearing screening devices and pulse oximeter are regularly used in the diagnosis of newborn disorders.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79924

The growth of the global newborn screening market can be ascribed to the rise in prevalence of critical congenital heart defects and government support. The U.S. has a national program of newborn screening tests to check for several different disorders that can be treated, if found very early in life.

North America dominated the global newborn screening market in 2019. This trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early new product adoption, high prevalence rate of critical congenital heart diseases, and presence of major players are expected to drive the newborn screening market in North America. Asia Pacific is anticipated to be a highly lucrative region of the global newborn screening market during the forecast period. The market in the region is projected to expand at a high CAGR during the forecast period.

Request for Analysis of COVID-19 Impact on Newborn Screening Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79924

Rise in Prevalence of Critical Congenital Heart Defects and Government Support to Drive Global Market

Rise in prevalence and incidence of critical congenital heart diseases across the globe are driving the global newborn screening market. According to the National Center for Biotechnology Information, about 1.35 million babies are born with congenital heart disease each year across the globe. According to the Indian Academy of Pediatrics, more than 200,000 children are estimated to be born with CHD in India every year. About one-fifth of these suffer from critical heart disease that requires early intervention.

Supportive governmental programs and increase in funding for neonatal research also create a favorable environment for the expansion of the market. For instance, in June 2018, the American Society of Hematology (ASH) led a campaign to fight the sickle cell disease in Africa and urged governments, particularly in Sub-Saharan Africa, to invest in newborn screening of the disease.

Buy Newborn Screening Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79924&ltype=S

Instruments to Dominate Newborn Screening Market

In terms of product, the global newborn screening market has been bifurcated into instruments and assay kits. The instruments segment has been split into tabletop and point-of-care testing. The instruments segment dominated the global newborn screening market in 2019. This trend is likely to continue during the forecast period. Instruments allow early detection and management of congenital disorders, thereby providing a better life to the affected infant. This is estimated to boost the segment during the forecast period. Major market players are focusing on the launch of new tabletop and point-of-care testing instruments for newborn screening. This is also likely to propel the segment during the forecast period.

Assay kits was the second-largest segment of the global market in 2019, in terms of market share. Increase in use of assay kit in newborn screening is projected to fuel the growth of the segment.

Ask For Discount: Top of Form

For

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4581

North America to Dominate Newborn Screening Market

In terms of region, the global newborn screening market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global newborn screening market in 2019, followed by Europe. North America’s large market share can be ascribed to the increase in number of infants with critical congenital heart diseases, new product launches, and presence of major players in the region. The newborn screening market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2031. This can be ascribed to the presence of developing countries with commercial hubs, expanding business organizations, rise in birth rate, improvement in healthcare infrastructure, and increase in investments by companies in research and development activity.

Competition Landscape of Newborn Screening Market

The global newborn screening market is fragmented in terms of number of players. Key players operating in the global market include PerkinElmer, Inc., Trivitron Healthcare, Natus Medical Incorporated, Medtronic Plc, Thermo Fisher Scientific, Inc, Bio-Rad Laboratories, Inc., GE Healthcare (General Electric Company), ZenTech S.A., MP BIOMEDICALS, Baebies, Inc. and Masimo.

Browse More Trending Reports by Transparency Market Research:

Downstream Processing Market:

The latest advancements in downstream processing include ligand technologies for purifying RNA and COVID-19 vaccines. Companies in the downstream processing market are in many talks such as Navigo Proteins and Repligan, who have developed an affinity ligand targeting the SARS-CoV-2 spike protein for the purification of COVID-19 vaccines. They are focusing on the development and validation of a related affinity chromatography resin, which improves yield during the manufacturing of COVID-19 vaccines.

Minimally Invasive Surgery Market:

The laparoscopic surgery is associated with the establishment and maintenance of an artificial pneumoperitoneum, which increases the risk of exposure to aerosol by the operation team. This is anticipated to create business expansion challenges for stakeholders in the minimally invasive surgery market, as previously HIV, activated Corynebacterium, and papillomavirus have been detected in surgical smoke where several doctors were infected. Hence, stakeholders are following guidelines laid down by the Centers for Disease Control and Prevention (CDC) to ensure continuity in healthcare services.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/